Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2026-06-03 17:33:45 ET · period of report 2026-06-01 · accession 0001780088-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-03 17:33 | 2026-06-01 | STOK | Ticho Barry | Chief MEDICAL Off | S - Sale | $30.58 | -1,795 | 34.8K | -5% | -$54.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | S | D | 1,795 | $30.58 | 34,826 | D | — | — | (F1) This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025. |